Earnings Call Transcript - Q1FY21 for Neuland Laboratories

Neuland Laboratories Ltd.

NSE: NEULANDLAB | BSE: 524558 | ISIN: INE794A01010 | Industry: Pharmaceuticals
| Expensive Performer

13296.0000 197.00 (1.50%)

NSE Aug 11, 2025 15:31 PM

26.54% Fall from 52W High

Volume: 34,168

Conference/Earnings Calls Alerts

Neuland Laboratories Ltd.

04 Aug 2020

13296.00

1.50%

Earnings Call Transcript - Q1FY21 for Neuland Laboratories

Conference Call with Neuland Labs Management and Analysts on Q1FY21 Performance and Outlook. Listen to the full earnings transcript.

More from Neuland Laboratories Ltd.

Recommended

IPO action stays active with four new issues and six listings this week

| 11 Aug 2025, 06:17PM

Market closes higher, L&T wins an order worth over Rs 15,000 crore from Adani Power

Trendlyne Marketwatch | 11 Aug 2025, 03:56PM

Chinese supply disruptions accelerate Neuland's growth trajectory